Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Carr

Showing results (811-820 of 830) with videos related to

Pageof 83
Sort By:
The American Journal of Medicine|May 12, 2024
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDHarlan M Krumholz, Mitsuaki Sawano, Bornali Bhattacharjee, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
De novo design of metal-oxide templating proteinsAmijai Saragovi, Harley Pyles, Timothy F Huddy, et al.
Basic Research in Cardiology|December 16, 2024
Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshopL Pearce, C Galán-Arriola, R M Bell, et al.
Plos Biology|May 22, 2018
Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMRDaniel Stöppler, Alex Macpherson, Susanne Smith-Penzel, et al.
Journal of Medicinal Chemistry|July 20, 1999
Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activitiesA G Taveras, J Deskus, J Chao, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylationA K Mallams, F G Njoroge, R J Doll, et al.
Basic Research in Cardiology|August 15, 2022
Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular WorkshopR M Bell, M Basalay, H E Bøtker, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
De novo design of protein nanoparticles with integrated functional motifsCyrus M Haas, Sanela Rankovic, Hanul K Lewis, et al.
Science (New York, N.Y.)|December 15, 1989
Voyager planetary radio astronomy at neptuneJ W Warwick, D R Evans, G R Peltzer, et al.
Mabs|September 4, 2020
Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of actionMark Austin, Daniel Burschowsky, Denice T Y Chan, et al.
Pageof 83

Showing results (811-820 of 830) with videos related to

Sort By:
Pageof 83
The American Journal of Medicine|May 12, 2024
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDHarlan M Krumholz, Mitsuaki Sawano, Bornali Bhattacharjee, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
De novo design of metal-oxide templating proteinsAmijai Saragovi, Harley Pyles, Timothy F Huddy, et al.
Basic Research in Cardiology|December 16, 2024
Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshopL Pearce, C Galán-Arriola, R M Bell, et al.
Plos Biology|May 22, 2018
Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMRDaniel Stöppler, Alex Macpherson, Susanne Smith-Penzel, et al.
Journal of Medicinal Chemistry|July 20, 1999
Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activitiesA G Taveras, J Deskus, J Chao, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylationA K Mallams, F G Njoroge, R J Doll, et al.
Basic Research in Cardiology|August 15, 2022
Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular WorkshopR M Bell, M Basalay, H E Bøtker, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
De novo design of protein nanoparticles with integrated functional motifsCyrus M Haas, Sanela Rankovic, Hanul K Lewis, et al.
Science (New York, N.Y.)|December 15, 1989
Voyager planetary radio astronomy at neptuneJ W Warwick, D R Evans, G R Peltzer, et al.
Mabs|September 4, 2020
Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of actionMark Austin, Daniel Burschowsky, Denice T Y Chan, et al.
Pageof 83